Are salmeterol's beneficial effects on corticosteroid action in the airways executed at the epithelial barrier?

about

Year in review 2013: Chronic obstructive pulmonary disease, asthma and airway biology.

P2860

Q38202680-6B23C721-5A3E-4E8C-838A-062C7012787E

P2860

Are salmeterol's beneficial effects on corticosteroid action in the airways executed at the epithelial barrier?

Item

http://www.wikidata.org/entity/Q45990688

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Are salmeterol's beneficial ef ...... ted at the epithelial barrier?

@en

Are salmeterol's beneficial ef ...... ted at the epithelial barrier?

@nl

type

Item

label

Are salmeterol's beneficial ef ...... ted at the epithelial barrier?

@en

Are salmeterol's beneficial ef ...... ted at the epithelial barrier?

@nl

prefLabel

Are salmeterol's beneficial ef ...... ted at the epithelial barrier?

@en

Are salmeterol's beneficial ef ...... ted at the epithelial barrier?

@nl

P1476

Are salmeterol's beneficial ef ...... ted at the epithelial barrier?

@en

P2093

Irene H Heijink

http://www.w3.org/2001/XMLSchema#string

Maarten van den Berge

http://www.w3.org/2001/XMLSchema#string

P2860

Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions.

Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy.

Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial.

Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.

E-cadherin: gatekeeper of airway mucosa and allergic sensitization.

Fluticasone uptake across Calu-3 cells is mediated by salmeterol when deposited as a combination powder inhaler.

Transport and local metabolism of budesonide and fluticasone propionate in a human bronchial epithelial cell line (Calu-3).

Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial.

Effects of budesonide/formoterol combination therapy versus budesonide alone on airway dimensions in asthma.

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

P304

1165-1166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1111/RESP.12180

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256608546

http://www.w3.org/2001/XMLSchema#string

P698

24033891

http://www.w3.org/2001/XMLSchema#string

Are salmeterol's beneficial effects on corticosteroid action in the airways executed at the epithelial barrier?

about

P2860

P2860

Are salmeterol's beneficial effects on corticosteroid action in the airways executed at the epithelial barrier?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698